Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,746 | 222,564 | 94,155 | 65,296 | 47,674 |
| Marketable Securities | 116,433 | 43,029 | 133,831 | 92,828 | 75,493 |
| Other current assets | 23,287 | 0 | 0 | 0 | 0 |
| TOTAL | $177,621 | $276,127 | $235,538 | $163,185 | $125,493 |
| Non-Current Assets | |||||
| PPE Net | 6,166 | 17,075 | 10,013 | 4,926 | 1,638 |
| Other Non-Current Assets | 24,449 | 30,169 | 644 | 417 | 2,302 |
| TOTAL | $30,615 | $47,244 | $10,657 | $5,343 | $3,940 |
| Total Assets | $208,236 | $323,371 | $246,195 | $168,528 | $129,433 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,793 | 2,144 | 2,448 | 2,483 | 2,663 |
| Accrued Expenses | 10,823 | 13,094 | 6,392 | 5,050 | 2,802 |
| TOTAL | $64,061 | $18,605 | $8,840 | $7,533 | $5,465 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,316 | 23,289 | 807 | 546 | 434 |
| TOTAL | $3,316 | $23,289 | $807 | $546 | $434 |
| Total Liabilities | $67,377 | $41,894 | $9,647 | $8,079 | $5,899 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,244 | 38,546 | 38,137 | 24,076 | N/A |
| Common Shares | 4 | 4 | 3 | 2 | N/A |
| Retained earnings | -501,344 | -349,522 | -249,715 | -182,591 | -85,590 |
| Other shareholders' equity | -445 | -13 | 63 | 142 | 209,124 |
| TOTAL | $140,859 | $281,477 | $236,548 | $160,449 | $123,534 |
| Total Liabilities And Equity | $208,236 | $323,371 | $246,195 | $168,528 | $129,433 |